BRIM Biotechnology, Inc. (TPEX: 6885)
Taiwan
· Delayed Price · Currency is TWD 48.95
+0.35 (0.72%)
Sep 11, 2024, 2:59 PM CST
BRIM Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -659.76 | -688.02 | -274.28 | -105.45 | -87.94 | -118.77 |
| Depreciation & Amortization | 6.12 | 5.41 | 3.97 | 3.82 | 3.81 | 4.91 |
| Loss (Gain) From Sale of Assets | -0.01 | -0.01 | - | - | -48.79 | - |
| Loss (Gain) From Sale of Investments | - | - | - | -32.87 | -26.77 | - |
| Loss (Gain) on Equity Investments | 21.49 | 24.59 | 62.62 | 47.94 | 9.66 | - |
| Stock-Based Compensation | 47.98 | 47.78 | 35.32 | 7.07 | 2.33 | 1.15 |
| Other Operating Activities | -19.88 | -4.38 | 0.24 | 0.27 | -18.09 | -3.43 |
| Change in Accounts Receivable | -2.72 | -1.41 | -0.32 | -0.01 | 2.44 | -2.18 |
| Change in Accounts Payable | 7.51 | 19.67 | 4.14 | -31.77 | 37.27 | 2.67 |
| Change in Unearned Revenue | - | - | - | -1.12 | 1.12 | - |
| Change in Other Net Operating Assets | 0.31 | -0.51 | -3.57 | -0.45 | -2.16 | 1.59 |
| Operating Cash Flow | -598.96 | -596.89 | -171.87 | -112.57 | -127.12 | -114.06 |
| Capital Expenditures | -2.09 | -2.26 | -1.11 | -0.78 | -0.37 | -0.07 |
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | - |
| Divestitures | - | - | - | - | -137.57 | - |
| Sale (Purchase) of Intangibles | -2.44 | -1.44 | -0.11 | - | - | - |
| Investment in Securities | -537.64 | -747.63 | 23.84 | 119.34 | - | - |
| Other Investing Activities | -0.07 | -0.11 | 0 | -0 | -2.29 | - |
| Investing Cash Flow | -542.22 | -751.43 | 22.63 | 118.56 | -140.23 | -0.07 |
| Long-Term Debt Repaid | - | -4.18 | -3.68 | -3.6 | -3.51 | -3.44 |
| Net Debt Issued (Repaid) | -4.22 | -4.18 | -3.68 | -3.6 | -3.51 | -3.44 |
| Issuance of Common Stock | 1,463 | 1,463 | 591.16 | 314.33 | 1.02 | - |
| Other Financing Activities | - | - | - | - | - | 171.29 |
| Financing Cash Flow | 1,458 | 1,458 | 587.49 | 310.73 | -2.49 | 167.85 |
| Foreign Exchange Rate Adjustments | - | - | - | - | 5.96 | -6.78 |
| Net Cash Flow | 317.1 | 110.01 | 438.24 | 316.72 | -263.88 | 46.94 |
| Free Cash Flow | -601.05 | -599.15 | -172.98 | -113.35 | -127.48 | -114.13 |
| Free Cash Flow Margin | -667836.67% | -665723.33% | -32885.74% | -31485.83% | -140.45% | - |
| Free Cash Flow Per Share | -5.38 | -5.96 | -2.43 | -1.91 | -2.17 | -1.94 |
| Cash Interest Paid | 0.1 | 0.15 | 0.08 | 0.11 | 0.07 | 0.12 |
| Cash Income Tax Paid | - | -0.07 | -0.13 | -0.05 | 9.13 | 0.19 |
| Levered Free Cash Flow | -383.61 | -371.06 | -97.94 | -81.3 | -55.43 | - |
| Unlevered Free Cash Flow | -383.55 | -370.97 | -97.89 | -81.23 | -55.39 | - |
| Change in Net Working Capital | 0.08 | -13.37 | -0.49 | 33.08 | -35.96 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.